Allison Stange lost 40 pounds since starting Zepbound in April 2024, improving both her blood pressure and sleep apnea. Now ...

The drugs, from a class of digestion-slowing medicines known as GLP-1 agonists, have eaten into demand at some big companies, ...

The weight-loss drug revolution is reshaping the health and wellness industry, forcing companies to adapt or face the same ...

Presented by The Coalition to Strengthen America’s Healthcare{beacon} Health Care Health Care   The Big Story Kennedy on ...

Amid concerns over trade restrictions and a weakening economy, some investors are seeking stability in dividend-paying stocks—a traditional defensive strategy.

US pharma major Eli Lilly (NYSE: LLY) yesterday announced executive leadership transitions that will further enhance the ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

Improving yourself to lead a genuinely more purposeful, healthier, and happier life isn’t a sprint—it's a marathon. The ...

If you're following the GLP-1 (Ozempic and other prescription weight-loss medications) scene, you may have read that the FDA ...